Related references
Note: Only part of the references are listed.Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
J. -C. Soria et al.
ANNALS OF ONCOLOGY (2013)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Petra Hamerlik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Neuropilin-1 expression in cancer and development
Adrian M. Jubb et al.
JOURNAL OF PATHOLOGY (2012)
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours
Benjamin Beck et al.
NATURE (2011)
Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration
Yanmei Lu et al.
MABS (2009)
Neuropilin-1 Upholds Dedifferentiation and Propagation Phenotypes of Renal Cell Carcinoma Cells by Activating Akt and Sonic Hedgehog Axes
Ying Cao et al.
CANCER RESEARCH (2008)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Targeting neuropilin 1 as an antitumor strategy in lung cancer
Tse-Ming Hong et al.
CLINICAL CANCER RESEARCH (2007)
cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis
D. Wu et al.
ONCOGENE (2007)
Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition
Tsukasa Baba et al.
GYNECOLOGIC ONCOLOGY (2007)
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan et al.
CANCER CELL (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Non-angiogenic functions of VEGF in breast cancer
Arthur M. Mercurio et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
JS Wey et al.
BRITISH JOURNAL OF CANCER (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract
DE Hansel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect
E Castro-Rivera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma
T Kawakami et al.
CANCER (2002)
VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding
S Soker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes
Z Gluzman-Poltorak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer
KJ O'Byrne et al.
BRITISH JOURNAL OF CANCER (2000)
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
ML Gagnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
